What is the recommended treatment for Clostridioides difficile infection?

Treatment of Clostridioides difficile Infection

For an initial episode of CDI, fidaxomicin 200 mg twice daily for 10 days is the preferred first-line treatment, with vancomycin 125 mg four times daily for 10 days as an acceptable alternative. 1

Initial Episode Treatment Algorithm

Preferred First-Line Therapy

• Fidaxomicin 200 mg orally twice daily for 10 days 1
  • This is the strongest recommendation from the 2021 IDSA/SHEA guidelines
  • Implementation depends on available resources (cost considerations)
  • Associated with lower recurrence rates compared to vancomycin

Alternative First-Line Therapy

• Vancomycin 125 mg orally four times daily for 10 days 1
  • Remains an acceptable alternative when fidaxomicin is unavailable or cost-prohibitive
  • Equally effective for initial cure rates

Last-Resort Option (Nonsevere CDI Only)

• Metronidazole 500 mg orally three times daily for 10-14 days 1
  • Only use if vancomycin and fidaxomicin are unavailable
  • Restricted to nonsevere CDI defined by:
    • White blood cell count ≤15,000 cells/μL AND
    • Serum creatinine <1.5 mg/dL
  • Avoid repeated courses due to cumulative, potentially irreversible neurotoxicity 2

Fulminant CDI (Medical Emergency)

For fulminant CDI, use high-dose vancomycin 500 mg orally four times daily PLUS intravenous metronidazole 500 mg every 8 hours. 1

Defining Fulminant CDI

• Hypotension or shock
• Ileus
• Megacolon

Treatment Approach

• Vancomycin 500 mg orally (or via nasogastric tube) four times daily 1
• Add IV metronidazole 500 mg every 8 hours (strong recommendation) 1
• If ileus present: Add rectal vancomycin 500 mg in 100 mL normal saline every 6 hours as retention enema 2
• Consider early surgical consultation for subtotal colectomy if deteriorating

First Recurrence

For first recurrence, fidaxomicin is preferred, with tapered/pulsed vancomycin as the alternative. 1

Preferred Options

1. Fidaxomicin 200 mg twice daily for 10 days 1

   • OR fidaxomicin 200 mg twice daily for 5 days, then once every other day for 20 days

2. Vancomycin tapered and pulsed regimen 1:

   • 125 mg four times daily for 10-14 days
   • Then 125 mg twice daily for 7 days
   • Then 125 mg once daily for 7 days
   • Then 125 mg every 2-3 days for 2-8 weeks

3. Standard vancomycin 125 mg four times daily for 10 days (if metronidazole was used initially) 1

Adjunctive Therapy

• Bezlotoxumab 10 mg/kg IV once during antibiotic administration 1
  • Monoclonal antibody against C. difficile toxin B
  • Reduces recurrence risk
  • Caution in congestive heart failure patients (FDA warning)
  • Limited data when combined with fidaxomicin

Second or Subsequent Recurrence

For multiple recurrences, continue antibiotic therapy through at least 2 recurrences (3 total CDI episodes) before considering fecal microbiota transplantation. 1

Treatment Options (in order of preference)

1. Fidaxomicin 200 mg twice daily for 10 days (or extended regimen) 1
2. Vancomycin tapered and pulsed regimen (as above) 1
3. Vancomycin 125 mg four times daily for 10 days followed by rifaximin 400 mg three times daily for 20 days 1
4. Fecal microbiota transplantation (after failing appropriate antibiotic treatments for ≥2 recurrences) 1

Critical FMT Safety Considerations

The FDA has issued multiple safety alerts since 2019 regarding FMT 1:

• Documented transmission of pathogenic E. coli from donor to recipients, resulting in illness and deaths
• Potential SARS-CoV-2 transmission risk
• Only use FMT after appropriate screening of donor and donor fecal specimens per FDA recommendations

Key Clinical Pearls

Common Pitfalls to Avoid

1. Never use metronidazole as first-line when vancomycin or fidaxomicin are available - it is inferior and no longer recommended 2
2. Avoid repeated metronidazole courses - cumulative neurotoxicity risk 2
3. Don't delay treatment in fulminant cases - start empirically before lab confirmation 2
4. Discontinue inciting antibiotics immediately when possible 2

Severity Assessment

• Nonsevere: WBC ≤15,000 cells/μL AND creatinine <1.5 mg/dL
• Severe: WBC ≥15,000 cells/μL OR creatinine >1.5 mg/dL
• Fulminant: Hypotension/shock, ileus, or megacolon

Treatment Duration

• Standard courses are 10 days for most regimens
• Consider extending to 14 days if delayed response (particularly with metronidazole) 2

Emerging Evidence

Recent real-world data confirms fidaxomicin's superiority, showing a 63% reduction in composite outcomes (clinical failure, 30-day relapse, or CDI-related death) compared to vancomycin 3. A 2026 trial demonstrated that a 4-week vancomycin pulse and taper regimen had 99% probability of preventing early recurrence at day 38 compared to standard 2-week pulse 4.